NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Sam Altman, Jensen Huang, and Oracle push back on reports of tension over OpenAI’s deal with Nvidia.Read More